Nemera and Zollner announce partnership for the development of electronic drug delivery devices
The new alliance will enable Nemera to offer enhanced connected drug delivery device solutions to customers and patients.
Nemera, world leader in design, development and manufacturing of drug delivery device solutions for the pharmaceutical, biotechnology and generic industries, today announced a partnership with Zollner Elektronik AG, one of the largest electronic manufacturing service providers in the world. Zollner is specialized in advanced mechatronics for Healthcare & Life Sciences, Railway Technology, Aerospace & Defense, Automotive Technology and many other sectors.
As a partner-of-choice, Zollner will support the design, development and manufacturing of electronic drug delivery systems for both, Nemera’s proprietary and customer owned products. This collaboration will begin with Nemera’s Symbioze®, a high-volume wearable injection device. Nemera will entrust the development of the electronics & software part of Symbioze® to Zollner.
“From the very beginning, Nemera has been a remarkable match for Zollner on both a technological and human level for mutually developing groundbreaking solutions toward a sustainable society. We are also very pleased to be able to support our partner at the largest international trade show for the pharmaceutical sector in Frankfurt, CPHI 2022, to further deepen our already very intensive partnership and jointly open up new growth markets”, says Erwin Stöckinger, Senior VP Business Division Electronics at Zollner.
Bernhard Rohn, Strategy and Marketing Vice President at Nemera said, “This strategic alliance strengthens both Nemera and Zollner’s offering combining drug delivery device and pharmaceutical industry knowledge with electronics development and manufacturing knowledge in the medical industry. Together, we’ll strive to develop the devices of tomorrow for improved patient
At Nemera, we believe innovation truly thrives through collaboration that leverages knowledge for the advancement of science and benefit of the society. Our partnership with Zollner further strengthens our commitment to bringing superior value to customers and ultimately patients.
To download the Press Release: Click here
The family-owned company with its headquarters in Zandt is Europe’s market leader in the Electronics Manufacturing Services sector. Founded in 1965, it has grown organically to become a global player with around 12,000 employees and 23 locations around the globe. Zollner Elektronik AG is one of the three largest solution providers in Europe in the Healthcare & Life Sciences sector and belongs in the top ten globally with more than two decades of experience with highly complex medical technology products.
Its services encompass the complete product life cycle and cover segments of Medical Technology, Pharmaceutical Devices, Laboratory Equipment and Digital Health – the ideal prerequisites for supporting the transformation and technological progress in the area of Healthcare & Life Sciences.
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy.
We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards.
Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.